Growth Metrics

BioCorRx (BICX) Cash from Investing Activities (2016 - 2021)

BioCorRx (BICX) has disclosed Cash from Investing Activities for 10 consecutive years, with -$11995.0 as the latest value for Q4 2021.

  • Quarterly Cash from Investing Activities fell 324.3% to -$11995.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11995.0 through Sep 2022, up 70.62% year-over-year, with the annual reading at -$49997.0 for FY2021, 441.86% down from the prior year.
  • Cash from Investing Activities hit -$11995.0 in Q4 2021 for BioCorRx, up from -$35985.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $801.0 in Q3 2019 to a low of -$54968.0 in Q4 2019.
  • Historically, Cash from Investing Activities has averaged -$18854.6 across 4 years, with a median of -$11995.0 in 2021.
  • Biggest five-year swings in Cash from Investing Activities: soared 500.5% in 2019 and later plummeted 899.0% in 2020.
  • Year by year, Cash from Investing Activities stood at -$26184.0 in 2018, then tumbled by 109.93% to -$54968.0 in 2019, then soared by 94.86% to -$2827.0 in 2020, then crashed by 324.3% to -$11995.0 in 2021.
  • Business Quant data shows Cash from Investing Activities for BICX at -$11995.0 in Q4 2021, -$35985.0 in Q3 2021, and -$2017.0 in Q1 2021.